Personal information

No personal information available

Activities

Collapse all

Education and qualifications (2)

University of Michigan College of Pharmacy: Ann Arbor, MI, US

2014 to 2018
Qualification
Source: Self-asserted source
Jerry Li

University of California Berkeley: Berkeley, CA, US

2009 to 2013
Qualification
Source: Self-asserted source
Jerry Li

Works (14)

Population modeling analyses of crizotinib in pediatric patients with ALK‐positive advanced cancers

Pediatric Blood & Cancer
2024-09 | Journal article
DOI: 10.1002/pbc.31139
Contributors: Li Jerry; Lin Swan; Nickens Dana; Frank M. Balis; Emily Greengard; Xu Huiping
Source: check_circle
Crossref

Dosing of 3 Targeted Agents in Novel Drug Combinations Used at the Precision Medicine Clinic of the University of California San Diego.

Journal of hematology oncology pharmacy
2023-02-01 | Journal article
PMID: 36998525
PMC: PMC10054256
Contributors: Nikanjam M; Jose Tinajero; McGann M; Li J; Yang J; Shen F; Sicklick JK; Kato S; Capparelli E; Kurzrock R
Source: Self-asserted source
Jerry Li

Evaluation of the Effect of Proton Pump Inhibitors on the Efficacy of Dacomitinib and Gefitinib in Patients with Advanced Non-Small Cell Lung Cancer and EGFR-Activating Mutations

Oncology and Therapy
2021-06-13 | Journal article
DOI: 10.1007/s40487-021-00156-2
Part of ISSN: 2366-1070
Part of ISSN: 2366-1089
Source: Self-asserted source
Jerry Li

The Effect of Modafinil on the Safety and Pharmacokinetics of Lorlatinib: A Phase I Study in Healthy Participants

Clinical Pharmacokinetics
2021-05-03 | Journal article
DOI: 10.1007/s40262-021-01026-w
Contributors: Jerry Li; Yazdi K. Pithavala; Jason Gong; Robert R. LaBadie; Josué Kunjom Mfopou; Joseph Chen
Source: check_circle
Crossref

Pharmacokinetics and Safety of Glasdegib in Participants With Moderate/Severe Hepatic Impairment: A Phase I, Single-Dose, Matched Case-Control Study.

Clinical pharmacology in drug development
2020-12-23 | Journal article
DOI: 10.1002/cpdd.897
PMID: 33356019
Source: Self-asserted source
Jerry Li

Model Informed Development of VRC01 in Newborn Infants Using a Population Pharmacokinetics Approach

Clinical Pharmacology & Therapeutics
2020-08-31 | Journal article
DOI: 10.1002/cpt.2026
Part of ISSN: 0009-9236
Part of ISSN: 1532-6535
Source: Self-asserted source
Jerry Li

Pharmacokinetic Models to Characterize the Absorption Phase and the Influence of a Proton Pump Inhibitor on the Overall Exposure of Dacomitinib

Pharmaceutics
2020-04-07 | Journal article
DOI: 10.3390/pharmaceutics12040330
Part of ISSN: 1999-4923
Source: Self-asserted source
Jerry Li

Drugs for the Treatment of Zika Virus Infection

Journal of Medicinal Chemistry
2020-01-23 | Journal article
DOI: 10.1021/acs.jmedchem.9b00775
Part of ISSN: 0022-2623
Part of ISSN: 1520-4804
Source: Self-asserted source
Jerry Li

Effects of novel pyrrolomycin MP1 in MYCN amplified chemoresistant neuroblastoma cell lines alone and combined with temsirolimus

BMC Cancer
2019-12 | Journal article
DOI: 10.1186/s12885-019-6033-2
Part of ISSN: 1471-2407
Source: Self-asserted source
Jerry Li

The effect of proton pump inhibitors (PPI) on dacomitinib (DACO) pharmacokinetics and efficacy in non-small cell lung cancer (NSCLC) patients with activating epidermal growth factor receptor (EGFR) mutation

Annals of Oncology
2019-04 | Journal article
DOI: 10.1093/annonc/mdz063.022
ISSN: 0923-7534
Source: Self-asserted source
Jerry Li

Design, synthesis and evaluation of marinopyrrole derivatives as selective inhibitors of Mcl-1 binding to pro-apoptotic Bim and dual Mcl-1/Bcl-xL inhibitors

European Journal of Medicinal Chemistry
2015-01 | Journal article
DOI: 10.1016/j.ejmech.2014.11.035
Part of ISSN: 0223-5234
Source: Self-asserted source
Jerry Li

Marinopyrrole Derivatives as Potential Antibiotic Agents against Methicillin-Resistant Staphylococcus aureus (III)

Marine Drugs
2014-04-30 | Journal article
DOI: 10.3390/md12052458
Part of ISSN: 1660-3397
Source: Self-asserted source
Jerry Li

Cyclic Marinopyrrole Derivatives as Disruptors of Mcl-1 and Bcl-xL Binding to Bim

Marine Drugs
2014-03-07 | Journal article
DOI: 10.3390/md12031335
Part of ISSN: 1660-3397
Source: Self-asserted source
Jerry Li

Drug Discovery Using Chemical Systems Biology: Identification of the Protein-Ligand Binding Network To Explain the Side Effects of CETP Inhibitors

PLoS Computational Biology
2009-05-15 | Journal article
DOI: 10.1371/journal.pcbi.1000387
Part of ISSN: 1553-7358
Source: Self-asserted source
Jerry Li
How many people are using ORCID?